PARP1 and neoplasm: To further compare and validate the specific uptake of 68Ga-DOTA-Olaparib in different tumor models, we further selected the A549 models with lower PARP-1 expression for the 68Ga-DOTA-Olaparib biodistribution investigation (Figure.